How much is AmtixBio worth in 2025?

AmtixBio has a current valuation of N/A based on their IPO round and secondary market data.

How much funding has AmtixBio raised?

AmtixBio has raised $5.8M in total funding across 0 funding rounds.

AmtixBio

Website

Last updated: July 24, 2024

Current Valuation

N/A

As of July 24, 2024

Total Funding Raised

$5.8M

Last Round

IPO

$10.0K

Last Funding

Jul 2024

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

No funding history available

Funding data has not been imported for this company yet

Valuation Analysis

Current Valuation Metrics

AmtixBio is currently valued at N/A as of July 24, 2024. The company has raised a total of $5.8M in funding.

Investment Perspective

AmtixBio's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.

Track AmtixBio Valuation Updates

Get notified when AmtixBio raises new funding or valuation changes

Explore More Data

Detailed analysis for AmtixBio

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

What is AmtixBio Worth in 2025?

As of 2025, AmtixBio is valued at N/A, based on the company's IPO funding round in July 24, 2024. This valuation positions AmtixBio as one of the leading private companies in the sector.

AmtixBio Valuation History

AmtixBio's funding history demonstrates steady growth and investor confidence.

How AmtixBio Valuation is Determined

Private company valuations like AmtixBio's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:

Revenue growth and financial performance
Market opportunity and total addressable market (TAM)
Competitive positioning and market share
Management team strength and execution capability
Technology and intellectual property
Industry trends and investor sentiment

AmtixBio Valuation FAQs

Is AmtixBio profitable?

AmtixBio has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.

How does AmtixBio's valuation compare to competitors?

AmtixBio is valued at N/A, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.

When will AmtixBio IPO?

AmtixBio has not announced plans for an initial public offering. Until an IPO, investors can access AmtixBio shares through secondary market platforms.